Dr. Neeta D Kang has been sanctioned funds

DBT grant for BCRIC to study the early onset of brain tumours

Ludhiana, February 3rd, 2012 (Shalu Arora and Rector Kathuria)

Dr. Neeta D Kang, Head of Innovation at Betty Cowan Research and Innovation Center, Christian Medical College and Hospital, has been sanctioned funds by the Department of Biotechnology (DBT, Govt. of India) to study proteins involved in the early onset of brain tumours. As the Principal Investigator on the project, Dr. Kang said “We were granted funding in 2009 to study cancer stem cells and microRNAs in brain tumors by DBT. MicroRNAs are short non-coding nucleotides of 18 to 22 basepairs in length, which have been found to control many genes in the body. Their deregulation causes diseases. This new grant will help us investigate the early onset of brain tumors from “health cells”. We are hopeful that by studying select proteins that are involved in DNA replication and the levels to which these proteins are deregulated in cancer cells, we would be able to merge these data into our clinical bioinformatics database and develop a predictive model towards ‘personalized medicine’.”

Dr. Kang added, “Many times, in vitro and animal model studies do not translate well into clinical trials and fail. We are using patient samples which would give us “real-patient” information and results that are representing the molecular ‘make-up’ of the patients’ tumour.”

She is collaborating with Dr. Roma Isaacs, who is the Co-PI (Pathology, CMCH, Ludhiana), Dr. RK Gupta (Radiodiagnosis, Sanjay Gandhi PGI, Lucknow), Dr. Nuzhat Husain (Pathology, RMLIMS, Lucknow), Dr. Yashbir Dewan (Neurosurgery, Fortis Hospital, New Delhi) and Dr. Ramandeep Dang (Neurosurgery, Guru Gobind Singh Medical College, Faridkot). Science is about working in a multidisciplinary collaborative effort. Dr. Kang is very grateful for her collaborators.